Stay updated on SPEARHEAD 2: Clinical Trial in Recurrent Head and Neck Cancer
Sign up to get notified when there's something new on the SPEARHEAD 2: Clinical Trial in Recurrent Head and Neck Cancer page.

Latest updates to the SPEARHEAD 2: Clinical Trial in Recurrent Head and Neck Cancer page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new record revision v3.3.3 was added to the history, and the HHS Vulnerability Disclosure and revision v3.3.2 entries were removed.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedAdded revision v3.3.2 to the study record history and removed revision v3.3.1; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedThe Record History page now shows revision v3.3.1, replacing v3.2.0, reflecting an updated rendering of the study record history.SummaryDifference0.1%

- Check45 days agoChange DetectedThe funding and operating-status notice banner was removed from the page. This administrative notice did not alter the study record or its details.SummaryDifference0.7%

- Check60 days agoChange DetectedThe new screenshot shows minor UI/layout adjustments to header, navigation, and footer without altering study data and history content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check88 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference13%

Stay in the know with updates to SPEARHEAD 2: Clinical Trial in Recurrent Head and Neck Cancer
Enter your email address, and we'll notify you when there's something new on the SPEARHEAD 2: Clinical Trial in Recurrent Head and Neck Cancer page.